| Field | Specification |
|---|---|
| Species | |
| Applications | |
| Cell type | |
| Classification | |
| Tissue | |
| Disease | Normal |
| Biosafety level | |
| Storage | |
| Shipping | |
| Catalog no. (Mfr.) | |
| Main SKU |
Overview
Human Osteoblasts-Femoral (HOb-f) is a cell model used for research applications where physiologically relevant identity and donor background support interpretation of experimental readouts. Human osteoblast derived from Femur (Osteoblasts-Femoral) within the Musculoskeletal system.
Bone is a dynamic tissue, being continuously remodeled by thecoordinated actions of osteoclasts and osteoblast. Osteoblasts, the bone-formingcells, are derived originally from pluripotent mesenchymal stem cells. They synthesizeand secrete organic extracellular matrix, osteoid, which is composed primarily of type I collagen. Osteoid is calcified by osteoblasts and during this process the cells become encased in lacunae within the calcified material and become osteocytes. Osteoblasts express protease-activated receptor-1 and vascular endothelial cell growth factor [1]. Studies show that leukemia inhibitory factor can bind to the osteoblast cell surface and induce bone formation both in vitro and in vivo [2]. The balance between osteoblast recruitment, proliferation, differentiation and apoptosis in sutures between cranial bones is essential for calvarial bone formation [3]. iXCells Biotechnologies provides high quality Human Osteoblasts-Femoral (HOb-f), which are isolated from human femur and cryopreserved at P0, with >0.5 million cells in each vial. HOb-f are characterized by the cytochemical detection of AP and mineral deposition. These HOb-f are negative for HIV-1, HBV, HCV, mycoplasma, bacteria, yeast, and fungi and can further expand for 12 population doublings in Osteoblast Growth Medium (Cat# MD-0054) under the condition suggested by iXCells Biotechnologies.
Key elements and design rationale
- Cell identity: osteoblast (Primary Cells, Custom Cells)
- Source context: Femur; Osteoblasts-Femoral; Musculoskeletal
- Biosafety level: BSL-2 (follow your institution’s biosafety program and local regulations)
Product-specific elements (such as tissue source, donor background, and cell classification) help frame how results should be interpreted across assays and experimental conditions.
Biological background
Cells originating from the Musculoskeletal system are commonly studied to understand tissue-specific physiology, signaling, and responses to perturbations in controlled in vitro settings.
Across primary and specialty cell models, experimental outcomes can be influenced by donor heterogeneity, passage history, confluence, and media composition. For interpretation, it is common to validate key markers or functional phenotypes in the user’s assay context and to document culture variables consistently.
Research relevance and current trends
- Increasing use of primary and specialty cells to improve translational relevance for target biology and phenotypic screening.
- Adoption of 3D culture formats and co-culture systems to better capture tissue microenvironments and cell–cell interactions.
- Integration of functional readouts with single-cell and multi-omics profiling to connect phenotype with molecular state.
Common research applications
- Profile identity markers by flow cytometry or immunostaining in cultured cells
- Quantify functional responses to defined stimuli relevant to the model system
- Compare baseline phenotype across donors/conditions using gene expression profiling
- Evaluate matrix remodeling and differentiation programs in musculoskeletal cell models
- Screen compounds or genetic perturbations for phenotype modulation using viability or imaging endpoints
Interpretation typically focuses on how a perturbation (e.g., cytokine exposure, metabolic stress, genetic manipulation, or compound treatment) shifts marker profiles or functional readouts relative to an appropriate control matched for donor and culture variables.
Notes for experimental interpretation
- Donor-to-donor heterogeneity can influence baseline phenotype and treatment response; include biological replicates when feasible.
- Passage number, confluence, and media composition can shift gene expression and functional readouts; track and report these variables consistently.
- Contamination control (including routine mycoplasma monitoring) supports reproducibility in downstream assays.
- Use appropriate negative/positive controls for the readout (e.g., unstimulated controls, pathway agonists/antagonists) to contextualize observed changes.
Customization & Add-ons: Can't find the cell line you need—or require a custom cell-based solution for your project? We can help you source the best match or support custom cell line services for diverse research needs, including cell line sourcing and selection (species, tissue, and disease model matching), stable cell line engineering (overexpression, knockdown, or knockout via CRISPR/Cas9, shRNA, or sgRNA), reporter gene integration (GFP, RFP, luciferase, and other fluorescent or bioluminescent constructs), genome editing and knockin (point mutations, tagged endogenous proteins, conditional alleles), inducible expression systems (Tet-On/Off and other regulatable constructs), drug resistance marker selection (puromycin, G418, hygromycin, and others), custom growth and media optimisation for specific assay requirements, scale-up production for high-throughput screening campaigns, and authentication and QC services (STR profiling, mycoplasma testing, viability assessment). Click Talk to a Scientist to submit a request, email us at support@biohippo.com, or explore our Research Services for additional support—our team will follow up with feasibility details and next steps.
